Frontlight ResearchEarly access
Trial site
Madrid
- 5running trials
- 9closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Atopic dermatitis (eczema)2 trials
- Gastric and oesophageal cancer2 trials
- Multiple sclerosis2 trials
- Chronic spontaneous urticaria1 trial
- Haemophilia1 trial
- Mesothelioma1 trial
- Metastatic breast cancer1 trial
- Multiple myeloma1 trial
- Sickle cell disease1 trial
- Type 1 diabetes1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 24 trials
- Phase 34 trials
- Phase 12 trials
- Phase 1/21 trial
- Status
- Terminated5 trials
- Completed4 trials
- Active, not recruiting3 trials
- Recruiting2 trials
- Lead sponsor
- Sanofi13 trials
- Bioverativ, a Sanofi company1 trial
Running trials
Recruiting
Active, not recruiting
Study in Paediatric Patients With Atopic Dermatitis Treated With Dupilumab in Spain
Recruiting
Active, not recruiting
Active, not recruiting
Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis (AD)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Multiple myeloma1 recruiting
- Sickle cell disease1 recruiting
Closed trials
Recruiting
Terminated
Terminated
Terminated
Terminated
Completed
Completed
Completed
Terminated
Site data: ClinicalTrials.govUpdated 15 Nov 2026